Estimated read time 3 min read

GlaxoSmithKline’s Arexvy vaccine shows promise in protecting adults aged 50-59 against RSV

In a significant development, GlaxoSmithKline (GSK) announced promising results from a late-stage clinical trial for their vaccine, Arexvy, which exhibits the potential to protect adults [more…]

Estimated read time 2 min read

Abbott’s Biowearable shines in successful U.K. performance

Biowearables represent a cutting-edge revolution in healthcare technology. These innovative devices are designed to monitor various physiological parameters within the human body, offering real-time insights [more…]

Estimated read time 4 min read

Individuals eager for Covid boosters are not receiving them as intended

The transition of responsibility for distributing Covid-19 vaccines from federal agencies to the commercial market has encountered significant challenges. Many individuals seeking Covid-19 booster shots [more…]

Estimated read time 2 min read

Unexpected influenza outbreak sweeps through Japan as immunity drops following COVID-19

According to data from the health ministry, there has been a remarkable 57% increase in the number of newly reported influenza cases at designated medical [more…]